Description and Brand Names
Información sobre medicamentos proporcionada por: IBM Micromedex
US Brand Name
Idelalisib is used in combination with rituximab to treat chronic lymphocytic leukemia (CLL) that has come back after other treatment. Idelalisib interferes with the growth of cancer cells, which are eventually destroyed by the body. It is an antineoplastic agent (cancer medicine).
This medicine is available only with your doctor's prescription.
This product is available in the following dosage forms: